BSE filing, BSE: 544611. Summary written from the filing by ALFA Finder's alert engine.
Mahamaya Lifesciences Ltd: key numbers
- Share price
- ₹171.00
- Market cap
- ₹400.2 Cr
- Revenue (annual)
- ₹329.3 Cr
- Net profit (annual)
- ₹16.72 Cr
- P/E (TTM)
- 23.9×Sector 34.5×
- Promoter holding
- 56.39%
- FII holding
- 2.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mahamaya Lifesciences Ltd
All →Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Mahamaya Lifesciences Management Change
Mahamaya Lifesciences Limited announced management changes including the appointment of Dr. Bhagirath Choudhary and re-appointment of two Independent Directors. The MD and Executive Director were also re-designated.
Mahamaya Lifesciences Annual General Meeting
Mahamaya Lifesciences Limited held its 24th Annual General Meeting on September 29, 2026. Shareholders considered resolutions including financial statement adoption, director re-appointments, and management re-designations.
Mahamaya Lifesciences Promoter Buying
Promoter Prashant Krishnamurthy acquired 7,200 equity shares of Mahamaya Lifesciences Ltd through open market purchases on BSE.
- Promoter stake change
- +0.02%
Mahamaya Lifesciences Annual Report
Mahamaya Lifesciences Limited has filed its Annual Report for the financial year 2025-26. The document details the company's financial and operational performance.
Mahamaya Lifesciences Annual General Meeting
Mahamaya Lifesciences Limited has issued the notice for its Annual General Meeting scheduled on September 29, 2026. The agenda includes financial adoption and various director appointments.
Other business update announcements
All →Cybele Industries Business Update
Cybele Industries disclosed joint venture discussions with a third party, still at an initial stage. No agreement has been executed and no value is stated.
Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Vascon Engineers Business Update
Vascon Engineers awarded Neobridge Realty LLP a Rs.72 Crore shell and core work contract over 25 months. The contract is excluding GST and is described as ordinary course of business.
- Value
- ₹72.00 Cr
- Execution
- 25 months
Meesho Business Update
Meesho's Q2 FY27 shareholders' letter reports NMV up 23% YoY to ₹12,911 crore. Festive timing moved the Mega Blockbuster Sale into Q3.
Dhruv Consultancy Services Business Update
Dhruv Consultancy received an empanelment letter of intent for DPR work for Chhattisgarh government departments, valid for 36 months. No contract value or allotted work was disclosed.
- Execution
- 36 months
Peshwa Wheat Business Update
Peshwa Wheat reported unaudited half-year revenue of about Rs.129 Cr for September 2026, up from Rs.109 Cr. The company attributes growth to core wheat processing and by-product utilisation.
- Value
- ₹129.0 Cr